Literature DB >> 2153961

Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma.

D A Greenhalgh1, D J Welty, A Player, S H Yuspa.   

Abstract

Previous studies have implicated the rasHa oncogene in the initiation of skin carcinogenesis and the fos oncogene in malignant progression of premalignant skin cell lines. To determine if these two oncogenes are sufficient to convert normal keratinocytes to cancer cells, freshly isolated mouse keratinocytes were coinfected with replication-defective (psi-2) v-rasHa and v-fos viruses in culture. When tested in nude mice within several days of infection, v-fos/v-rasHa-coinfected keratinocytes produced squamous cell carcinomas. Introduction of v-fos alone resulted in normal or hyperplastic skin, whereas v-rasHa alone produced squamous papillomas. These results indicate that two oncogenes are sufficient to produce the malignant phenotype in epidermal cells. Furthermore, they clearly link the fos oncogene with malignant conversion. Since fos acts as a transcriptional regulator of other genes, malignant conversion may be an indirect consequence of the overexpression of the fos-encoded protein leading to a change in the expression of fos-controlled cellular genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153961      PMCID: PMC53321          DOI: 10.1073/pnas.87.2.643

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Retroviral transfer of a murine cDNA for multidrug resistance confers pleiotropic drug resistance to cells without prior drug selection.

Authors:  B C Guild; R C Mulligan; P Gros; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

2.  The complete cDNA and deduced amino acid sequence of a type II mouse epidermal keratin of 60,000 Da: analysis of sequence differences between type I and type II keratins.

Authors:  P M Steinert; D A Parry; E L Racoosin; W W Idler; A C Steven; B L Trus; D R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Construction and applications of a highly transmissible murine retrovirus shuttle vector.

Authors:  C L Cepko; B E Roberts; R C Mulligan
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

4.  Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters.

Authors:  A Schönthal; P Herrlich; H J Rahmsdorf; H Ponta
Journal:  Cell       Date:  1988-07-29       Impact factor: 41.582

Review 5.  Fos-associated protein p39 is the product of the jun proto-oncogene.

Authors:  F J Rauscher; D R Cohen; T Curran; T J Bos; P K Vogt; D Bohmann; R Tjian; B R Franza
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

6.  Association of resistance to terminal differentiation with initiation of carcinogenesis in adult mouse epidermal cells.

Authors:  H Kawamura; J E Strickland; S H Yuspa
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

7.  Proto-oncogene expression during two-stage carcinogenesis in mouse skin.

Authors:  R Toftgard; D R Roop; S H Yuspa
Journal:  Carcinogenesis       Date:  1985-04       Impact factor: 4.944

8.  Keratinocytes blocked in phorbol ester-responsive early stage of terminal differentiation by sarcoma viruses.

Authors:  S H Yuspa; A E Kilkenny; J Stanley; U Lichti
Journal:  Nature       Date:  1985 Apr 4-10       Impact factor: 49.962

9.  Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts.

Authors:  J E Strickland; D A Greenhalgh; A Koceva-Chyla; H Hennings; C Restrepo; M Balaschak; S H Yuspa
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

10.  Common DNA binding site for Fos protein complexes and transcription factor AP-1.

Authors:  F J Rauscher; L C Sambucetti; T Curran; R J Distel; B M Spiegelman
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

View more
  20 in total

Review 1.  Retinoid pathway and cancer therapeutics.

Authors:  Nathan Bushue; Yu-Jui Yvonne Wan
Journal:  Adv Drug Deliv Rev       Date:  2010-08-03       Impact factor: 15.470

Review 2.  Epstein-Barr virus infection at mucosal surfaces: detection of genomic variants with altered pathogenic potential.

Authors:  J W Sixbey; P Shirley
Journal:  Springer Semin Immunopathol       Date:  1991

3.  Partial trisomies in two spontaneously arising long-lived human keratinocyte lines.

Authors:  J D Weaver; G Stetten; J W Littlefield
Journal:  In Vitro Cell Dev Biol       Date:  1991-08

4.  Exposure of organ cultures from human tracheal epithelium to chemical carcinogens and subsequent long-term co-cultivation with autologous isotopic fibroblasts.

Authors:  I Haas; P Koldovsky; U Ganzer
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

5.  Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells.

Authors:  Bokai Zhu; Combiz Khozoie; Moses T Bility; Christina H Ferry; Nicholas Blazanin; Adam B Glick; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

6.  Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.

Authors:  A B Glick; A B Kulkarni; T Tennenbaum; H Hennings; K C Flanders; M O'Reilly; M B Sporn; S Karlsson; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Expression of the carcinoma-associated keratin K6 and the role of AP-1 proto-oncoproteins.

Authors:  F Bernerd; T Magnaldo; I M Freedberg; M Blumenberg
Journal:  Gene Expr       Date:  1993

Review 8.  Transgenic mice and squamous multistage skin carcinogenesis.

Authors:  K Brown; A Balmain
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

9.  Overlapping loss of heterozygosity by mitotic recombination on mouse chromosome 7F1-ter in skin carcinogenesis.

Authors:  A B Bianchi; N M Navone; C M Aldaz; C J Conti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

10.  Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion.

Authors:  Satish B Cheepala; Weihong Yin; Zanobia Syed; Jennifer N Gill; Alaina McMillian; Heather E Kleiner; Mark Lynch; Rasiah Loganantharaj; Marjan Trutschl; Urska Cvek; John L Clifford
Journal:  Mol Cancer       Date:  2009-05-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.